Evaluating Alzheimer's disease biomarkers as mediators of age-related cognitive decline

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 01, 2017
Source ID
10.1016/j.neurobiolaging.2017.06.022

Entities

People

  • Dan Mungas
  • Doug Tommet
  • Joey A. Contreras
  • Rich Jones
  • Shawn Marks
  • Timothy J. Hohman

Organizations

  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • BioClinica
  • Biogen
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eisai
  • Eli Lilly and Company
  • GE HealthCare
  • Hoffmann-La Roche
  • Innogenetics
  • Johnson & Johnson
  • Laboratoires Servier
  • Lundbeck
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • Pfizer
  • Roche (United States)
  • Takeda Pharmaceutical Company
  • United States Department of Defense